Authors


Michael Vasconcelles, MD

Latest:

What’s Next for Real-World Evidence in Oncology?

Recent steps by FDA to promote the use of real-world evidence are to be commended, but the future demands a broader vision that makes greater use of growing sources of health care information.


Dawn Webster, MPAS, PA-C

Latest:

Teamwork Enhances Patient Experience: Linking TEAM and Net Promoter Scores

In 1386 providers, better teamwork related to higher patient Net Promoter Score (NPS), and the relationship between provider experience and NPS was mediated by teamwork.


Rebecca Kahn, MD, FACOG  | Image Credit: Thermo Fisher Scientific.
Rebecca Khan, MD, FACOG

Latest:

Contributor: More Informed Management of Preeclampsia Is Necessary

At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.


Stephen T. Parente, PhD, MPH, MS

Latest:

Comparing Spending Across Medicare Programs

As Medicare Advantage increasingly becomes the dominant form of Medicare coverage, Congress must improve transparency of programmatic costs and benefits to promote beneficiary choice.


Paige Organick-Lee, MPH

Latest:

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.


Lu Wang, PhD

Latest:

Inappropriate Wrist MRI: Did Guidelines Have an Impact?

This article analyzes the use of MRI in a national sample of patients with wrist pain before and after consensus guideline publication.



Kathleen Rowan, PhD

Latest:

Searching for the Policy-Relevant Treatment Effect in Medicare’s ACO Evaluations

The authors discuss multiple challenges to the production of policy-relevant results from evaluation of Medicare accountable care organizations (ACOs).


Joshua J. Solano, MD

Latest:

COVID-19 Control in the United States: The Case for Masking

In the control of COVID-19, the future perfect of the vaccine should not be the enemy of the present good, which is masking.


Michael J. Follick, PhD

Latest:

Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs

The Diabetes Care Rewards program offers a business case for health plans to promote engagement through use of contingent incentives, thus improving health outcomes and lowering costs.


Amy C. Lockwood, DNP

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Siva Namasivayam

Latest:

Contributor: The Future of Prior Authorization Under the Improving Seniors’ Timely Access to Care Act

Streamlining the prior authorization process can improve care accuracy and patient access to care, writes Siva Namasivayam, CEO of Cohere Health.


Shannon Lopez, LVN

Latest:

Preventive Care: Vaccines Matter

A database of information about more than 30,000 patients verified improved morbidity and mortality due to vaccines and preventive health care in prospective trials.


Amy M. Sawyer, PhD, RN

Latest:

Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use

Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.


Adrian Goh, MEc

Latest:

Budget Impact Analysis of Biosimilar Natalizumab in the US

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.


Teresa Rogstad, MPH

Latest:

Value-Based Care Through Postacute Home Health Under CMS PACT Regulations

Among a patient population defined by CMS postacute care transfer regulations, home health vs no postacute care was associated with reduced 30-day readmissions and costs.


K. Rajesh Kumar, MBBS

Latest:

Clinical Profile of COVID-19 Infection in Postvaccination Individuals

This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.


Nathalie McIntosh, PhD

Latest:

Association Between Use of Clinician Performance Information and Patient Experience

High patient experience scores were associated with the collection and use of any clinician performance information, especially with whether the practice shared this information internally to compare.


Kaustuv Bhattacharya, PhD

Latest:

Continuity of Opioid Prescribing Among Older Adults on Long-term Opioids

Among older adults with chronic noncancer pain on long-term opioid therapy, greater continuity of opioid prescribing was significantly associated with fewer opioid-related adverse outcomes.


Rachel Lipson, MA

Latest:

Rising Use of Surveillance Colonoscopy and Potential Impacts

The proportion of colonoscopies performed for postpolypectomy surveillance has increased significantly, particularly among older patients with limited life expectancy, raising concern for possible overuse.


Megan Callahan, MPH

Latest:

Industry-Informed Perspectives on the Benefits of Rideshare-Based Medical Transportation

Previous research on rideshare-based nonemergency medical transportation has limited generalizability due to the specific model studied, and the lack of trip-level data raises concerns of ecological fallacy.


Tiffany Iwamura, PharmD

Latest:

Evaluating Satisfaction With Pharmacist-Provided MTM Services in a Medicaid Population

Medication therapy management (MTM) services were performed with a cohort of Medicaid patients, and their satisfaction with the program was assessed as part of a quality improvement initiative.


Vandna Chaudhari, MHA

Latest:

Factors Associated With Lung Cancer Risk Factor Documentation

This cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.



Davida Kruger, MSN, APN-BC, BC-ADM

Latest:

CGM: Redefining Type 2 Diabetes Management

A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing real-time data that enables earlier interventions, supports treatment optimization, and helps managed care organizations justify broader CGM adoption for newly diagnosed patients.


Mark Sevco, MBA, MHA

Latest:

Consumer-Centric Approach to Enhance Access to Pediatric Specialty Care

The authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.


Roberta P. Lavin, PhD, FNP-BC, RN

Latest:

Nurse Practitioner Low-Value Care Ordering Practices: An Integrative Review

No generalized statements regarding nurse practitioners’ low-value care ordering practices can be made due to limited evidence, indicating a need for further research.


Douglas E. Wood, MD

Latest:

Factors Associated With Lung Cancer Risk Factor Documentation

This cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.


Ellis C. Dillon, PhD

Latest:

Primary Care Nurse Practitioner Management of Adolescent Behavioral Health

Personnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).


Matt Hoffman

Latest:

FDA Approves bluebird bio's Lovo-Cel Gene Therapy for Sickle Cell Disease

The decision was supported by efficacy data from 36 patients from the ongoing phase 1/2 HGB-206 trial (NCT02140554) and 2 patients in the phase 3 HGB-210 trial (NCT04293185). It was the second approval from FDA for a gene therapy for sickle cell disease.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo